Wockhardt · NSE: WOCKPHARMA · BSE: 532300
Q1 FY21 results · Apr–Jun 2020
Wockhardt reported revenue from operations of ₹598.27 crore (down 30.7% from Q1 FY20) and net profit of ₹759.75 crore for Q1 FY21 (Apr–Jun 2020), on a consolidated basis.
| Item | Q1 FY21 | Q1 FY20 | YoY | Q4 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 598.27 | 863.11 | −30.7% | 686.93 | −12.9% |
| Other income | 7.95 | 8.08 | −1.6% | 13.73 | −42.1% |
| Total income | 606.22 | 871.19 | −30.4% | 700.66 | −13.5% |
| Profit before tax | (336.24) | (77.86) | Loss widened | (95.13) | Loss widened |
| Net profit for the period | 759.75 | (36.88) | Turned profit | 68.51 | 11x |
| Attributable to shareholders of the company | 760.06 | — | — | 48.29 | 16x |
| EPS, basic (₹) | 68.64 | (4.06) | Turned profit | 4.36 | 16x |
| Net margin (%) | 127.0 | -4.3 | 10.0 |
| Item | Q1 FY21 | Q1 FY20 | YoY | Q4 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 177.58 | 352.21 | −49.6% | 162.21 | +9.5% |
| Other income | 9.74 | 8.61 | +13.1% | 12.62 | −22.8% |
| Total income | 187.32 | 360.82 | −48.1% | 174.83 | +7.1% |
| Profit before tax | (332.98) | (133.18) | Loss widened | (150.24) | Loss widened |
| Net profit for the period | 766.39 | (82.93) | Turned profit | (78.48) | Turned profit |
| EPS, basic (₹) | 69.21 | (7.49) | Turned profit | (7.08) | Turned profit |
| Net margin (%) | 431.6 | -23.5 | -48.4 |
Consolidated
- Filed with BSE
- 31 Aug 2020, 08:35 IST
- Board meeting
- 29 Aug 2020
- Period
- 01 Apr 2020 to 30 Jun 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 31 Aug 2020, 08:35 IST
- Board meeting
- 29 Aug 2020
- Period
- 01 Apr 2020 to 30 Jun 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE